Juglalin is primarily studied for its anti-inflammatory and antioxidant properties. It has shown potential in inhibiting the production of pro-inflammatory cytokines, making it relevant in research related to inflammatory diseases such as arthritis and asthma. It also exhibits antiviral activity, particularly in early-stage viral replication, suggesting possible use in developing treatments for certain viral infections. Additionally, juglalin demonstrates cytotoxic effects on some cancer cell lines, indicating its role in anticancer research, especially in targeting breast and liver cancer cells. Its ability to modulate cellular oxidative stress further supports its investigation in neurodegenerative disorders where oxidative damage plays a key role.